Anti-Human p34cdc2 Serine/Threonine Kinase - DyLight® 594

Leinco Technologies
Product Code: LEI-P314
Product Group: Primary Antibodies
CodeSizePrice
LEI-P314-50ug50 ug£159.00
Quantity:
LEI-P314-100ug100 ug£211.00
Quantity:
LEI-P314-200ug200 ug£291.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Mouse
Antibody Isotype: IgG2a
Antibody Clonality: Monoclonal
Antibody Clone: 17
Regulatory Status: RUO
Target Species: Human
Application: Flow Cytometry
Shipping:
2-8°C
Storage:
This DyLight® 594 conjugate is stable when stored at 2-8°C. Do not freeze.

Further Information

Concentration:
0.2 mg/ml
Conjugate/Tag/Label:
DyLight® 594
Format:
This DyLight® 594 conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
Formulation:
This DyLight® 594 conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
Immunogen:
Purified Recombinant Human p34cdc2 Serine/Threonine Kinase (>98%)
Long Description:
p34cdc2 is thought to be activated by cyclin through dephosphorylation at tyrosine residues. Activated p34cdc2 kinase is involved in a number of mitotic events such as nuclear envelope breakdown and chromosome condensation through phosphorylation of serine/threonine residues of substrates such as nuclear lamins, histones, pp60c-src, nucleolin and RNA polymerase II. It is then inactivated by a tyrosine kinase. Anti-p34cdc2 can be used in western blotting, immunoprecipitation and immunohistochemistry. The antibody precipitates an active kinase.
NCBI Gene:
983
Target:
p34cdc2 Serine/Threonine Kinase

References

1. Moreno, S. et al. (1990) Cell 61:5492. Ward, GE. et al. (1990) Cell 61:5613. Langan, TA. et al. (1989) Mol. Cell. Biol. 9:3860